Immune Checkpoint Inhibitors Pose ACTH Deficiency Risk

Immune checkpoint inhibitors, increasingly used to treat a variety of cancers, can cause unpredictable immune-related adverse events including endocrinopathies.
First Look

source https://www.medscape.com/viewarticle/989856?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost